Clinical Trial Update: Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pathological responses of colorectal cancer liver metastases resected after preoperative bevacizumab with FOLFOX or FOLFIRI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• FOLFOX

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED